4.7 Article

Predictors of Persistence After a Positive Depression Screen Among Adolescents

期刊

PEDIATRICS
卷 130, 期 6, 页码 E1541-E1548

出版社

AMER ACAD PEDIATRICS
DOI: 10.1542/peds.2012-0450

关键词

adolescent depression; screening; primary care

资金

  1. Group Health Community Foundation Child and Adolescent Grant Program
  2. University of Washington Royalty Research Fund
  3. Seattle Children's Hospital Steering Committee Award
  4. National Institute of Mental Health [5K23 MH069814]
  5. National Institutes of Health (NIH)
  6. Lilly
  7. Pfizer
  8. Forrest

向作者/读者索取更多资源

OBJECTIVE: To examine predictors of depression persistence after a positive screening test to inform management protocols for screened youth. METHODS: We conducted a cohort study of 444 youth (aged 13-17 years) from a large health care delivery system. Youth with depressive symptoms, based on a 2-item depression screen, were over-sampled for the baseline interview. Baseline assessments included the Patient Health Questionnaire 9-item (PHQ-9) depression screen as well as clinical factors that were hypothesized to influence depression persistence (family history of depression, functional impairment, perceived social support, anxiety symptoms, externalizing symptoms, and medical comorbidity). Logistic regression analysis was used to examine factors associated with the persistence of depression at 6 months postbaseline. RESULTS: Of 113 youth with a positive baseline screen (PHQ-9 >= 11), 47% and 35% continued to be positive at 6-week and 6-month follow-up, respectively. After controlling for treatment status, only 2 factors were significantly associated with depression persistence at 6 months: baseline depressive symptom score and continuing to have a positive screen at 6 weeks. For each 1-point increase on the PHQ-9 score at baseline, youth had a 16% increased odds of continuing to be depressed at 6 months (odds ratio: 1.16, 95% confidence interval: 1.01-1.34). Youth who continued to screen positive 6 weeks later had almost 3 times the odds of being depressed at 6 months (odds ratio: 2.89, 95% confidence interval: 1.09-7.61). CONCLUSIONS: Depressive symptom severity at presentation and continued symptoms at 6 weeks postscreening are the strongest predictors of depression persistence. Patients with high depressive symptom scores and continued symptoms at 6 weeks should receive active treatment. Pediatrics 2012;130:e1541-e1548

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据